|
A 3 year PhD fellowship is available in the Group of Structural Biology and Drug Development (Luecke
group) at the Centre for Molecular Medicine Norway (NCMM), University of Oslo (UiO).
The Group for Structural Biology and Drug Development investigates medically relevant proteins and protein complexes using biophysical, biochemical and structural approaches. The projects
aim at understanding structure-function relationships with an emphasis on drug discovery. We employ a variety of biochemical and biophysical techniques (x-ray crystallography, single particle cryo electron microscopy, DSF, ITC, SPR, HDX-MS, SAXS, molecular
dynamics simulations etc.). Externally funded projects include inhibitor discovery targeting the Helicobacter pylori pH acclimation system (a pH-gated urea channel and a cytoplasmic urease), and discovery of compounds that reactivate p53 cancer mutants in
vitro and in vivo. Additional projects are available.
The PhD student will also benefit from career development programs offered both at UiO, the Norwegian BioCat initiative as
well as the Nordic EMBL network of the Centre for Molecular Medicine, Norway. Online application required, deadline 31 Mar 2019: -- Prof. Hartmut Luecke Structural Biology and Drug Discovery Group Norwegian Centre for Molecular Medicine (NCMM), Nordic EMBL Partnership and Institute of Clinical Medicine, University of Oslo Dept. of Medical Biochemistry, Oslo University Hospital Oslo, Norway This message may contain confidential information and is for the sole use of the intended recipient(s). If you are not the intended recipient, do not use, distribute, or copy this e-mail. Please notify the UC Irvine Health – Compliance and Privacy Office via email at hacompliance@uci.edu or by phone 888-456-7006 immediately if you have received this e-mail in error. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of this message, which arise as a result of e-mail transmission. To unsubscribe from the CCP4BB list, click the following link: |